     |
By DAVID WALDSTEIN 04 Dec, 2013
-
Source: http://www.nytimes.com/2013/12/04/business/rare-cancer-treatments-cleared-by-fda-but-not-subject-to-scrutiny.html?partner=rss&emc=rss
--
Manage subscription | Powered by rssforward.com
Tuesday, 3 December 2013
Rare Cancer Treatments, Cleared by F.D.A. but Not Subject to Scrutiny
The F.D.A. allows the sale of some devices to treat small groups of patients without requiring proof that the devices work, or any rigorous study of the medical results.
-
Source: http://www.nytimes.com/2013/12/04/business/rare-cancer-treatments-cleared-by-fda-but-not-subject-to-scrutiny.html?partner=rss&emc=rss
--
Manage subscription | Powered by rssforward.com
-
Source: http://www.nytimes.com/2013/12/04/business/rare-cancer-treatments-cleared-by-fda-but-not-subject-to-scrutiny.html?partner=rss&emc=rss
--
Manage subscription | Powered by rssforward.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment